Medicine & Life Sciences
Acute Myeloid Leukemia
100%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
39%
pevonedistat
35%
Imatinib Mesylate
34%
Hematologic Neoplasms
29%
Myelodysplastic Syndromes
28%
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
28%
Therapeutics
28%
Leukemia
25%
Neoplasms
22%
Phosphotransferases
21%
KB004
20%
Protein-Tyrosine Kinases
20%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20%
Isocitrate Dehydrogenase
17%
Bone Marrow
17%
5'-oleoyl cytarabine
17%
Philadelphia Chromosome
16%
Primary Myelofibrosis
15%
troxacitabine
15%
Mutation
15%
Dasatinib
14%
Survival
14%
Receptor Protein-Tyrosine Kinases
14%
Enzyme Inhibitors
13%
Drug Development
13%
Clinical Trials
12%
Leukemia, Myeloid, Chronic Phase
11%
Vorinostat
11%
Hairy Cell Leukemia
10%
Safety
9%
Monoclonal Antibodies
9%
Pharmaceutical Preparations
9%
Proteins
8%
Needle Biopsy
8%
Benchmarking
8%
6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine
8%
Karyotype
8%
Tretinoin
8%
vosaroxin
8%
laromustine
8%
ivosidenib
8%
immunotoxin HA22
7%
AG-221
7%
Biopsy
7%
amonafide
7%
proto-oncogene proteins pim
7%
VX680
7%